With consumers turning more health conscious post-pandemic, the business of preventive healthcare has seen a boom across the archipelago. Indonesian DNA testing platform Asa Ren Pte Ltd recently raised $8.15 million in a pre-Series A funding round from London-based Naya Capital, Kejora Capital, Northstar Group, Top Harvest Capital, and others.
Asa Rén had issued shares worth $6.1 million earlier this month to investors including Kejora-SBI Orbit, PT Cakrawala Data Integrasi, and PT Diagnos Laboratorium Utama Tbk, according to DealStreetAsia DATA VANTAGE.